Cited by 33Liver Diseases and ImmunityCholesterol and Lipid MetabolismLipoproteins and Cardiovascular Health

Paradoxical elevation of serum cholesterol by clofibrate in patients with primary biliary cirrhosis

Open access
Schaffner, Fenton·1969·Gastroenterology

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0016-5085(19)33896-x

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Sperber, I. 1965. Biliary secretion of organic anions and its influence on bile flow , p. 457- 467. In W. Taylor [ed.), The biliary system .

Cited by

Sorted by citations

Authors
Schaffner, F.
Affiliations
City University of New York (US)
Corresponding author
Schaffner, Fenton
Venue
Gastroenterology
Publisher
Elsevier BV
Published
1969-09
Volume
57
Issue
3
Pages
253-255
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2463973101
Cited by
33
References
9
Citations by year
2023: 1 · 2020: 1 · 2018: 1 · 2015: 3 · 2014: 1 · 2013: 1 · 2012: 1
FWCI
2.60
Type
journal article
Language
en
Open access
Locations
  • Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (AM 03846)
  • U.S. Public Health Service
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
Keywords
clofibrate, primary biliary cirrhosis, xanthoma, adverse drug reactions, lipid-lowering therapy
MeSH terms
Hypolipidemic Agents, Cholesterol, Female, Humans, Hypercholesterolemia, Lipids, Liver Cirrhosis, Biliary, Male, Middle Aged, Xanthomatosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review